MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Study of HRS-9057 in Patients With Heart Failure and Volume Overload

Phase 1
Not yet recruiting
Conditions
Heart Failure With Volume Overload
Interventions
Drug: HRS-9057
Drug: Tolvaptan
First Posted Date
2024-07-18
Last Posted Date
2024-07-18
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Target Recruit Count
24
Registration Number
NCT06506994
Locations
🇨🇳

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath